Molecules 2011-01-01

Screening for compounds with aromatase inhibiting activities from Atractylodes macrocephala Koidz.

Hai Jiang, Jing Shi, Yuanyuan Li

Index: Molecules 16 , 3146-3151, (2011)

Full Text: HTML

Abstract

Ten compounds were isolated from the dichloromethane extract of Atractylodes macrocephala and their aromatase inhibiting activities were tested using an in vitro fluorescent-based aromatase assay. The results indicated that atractylenolide I, atractylenolide II and atractylenolide III had inhibition ratios of 94.56 ± 0.70%, 90.93 ± 1.41% and 86.31 ± 8.46%, respectively, at a concentration of 10 μM. We conclude from our results that atractylenolide and its derivates may serve as potential aromatase inhibitors (AIs) and thus merit continued study in the future.


Related Compounds

Related Articles:

GABA(A) receptor modulators from Chinese herbal medicines traditionally applied against insomnia and anxiety.

2012-02-15

[Phytomedicine 19 , 334-340, (2012)]

Quantitative analysis of atractylenolide I in rat plasma by LC–MS/MS method and its application to pharmacokinetic study

2012-01-01

[J. Pharm. Biomed. Anal. 58 , 172-176, (2012)]

Downregulation of matrix metalloproteinase-13 by the root extract of Cyathula officinalis Kuan and its constituents in IL-1β-treated chondrocytes.

2011-09-01

[Planta Med. 77 , 1528-1530, (2011)]

Atractylenolide-I sensitizes human ovarian cancer cells to paclitaxel by blocking activation of TLR4/MyD88-dependent pathway.

2014-01-01

[Sci. Rep. 4 , 3840, (2014)]

More Articles...